Showing results (731-740 of 789) with videos related to

Sort By:
Pageof 79
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 30, 2016
Comparison of prognostic and predictive impact of genomic or central grade and immunohistochemical subtypes or IHC4 in HR+/HER2- early breast cancer: WSG-AGO EC-Doc TrialO Gluz, C Liedtke, J Huober, et al.
NAR Cancer|February 26, 2025
The IGF2BP1 oncogene is a druggable m<sup>6</sup>A-dependent enhancer of YAP1-driven gene expression in ovarian cancerAnnekatrin Schott, Theresa Simon, Simon Müller, et al.
Geburtshilfe Und Frauenheilkunde|October 29, 2019
Update Breast Cancer 2019 Part 4 - Diagnostic and Therapeutic Challenges of New, Personalised Therapies for Patients with Early Breast CancerFlorian Schütz, Peter A Fasching, Manfred Welslau, et al.
Molecular Cancer Research : MCR|November 10, 2019
EZH2 Loss Drives Resistance to Carboplatin and Paclitaxel in Serous Ovarian Cancers Expressing ATMJohanna Naskou, Yvonne Beiter, Ruan van Rensburg, et al.
European Journal of Cancer (Oxford, England : 1990)|April 20, 2004
Cardiac safety of trastuzumab in combination with epirubicin and cyclophosphamide in women with metastatic breast cancer: results of a phase I trialM Untch, H Eidtmann, A du Bois, et al.
Zeitschrift Fur Geburtshilfe Und Neonatologie|June 10, 2025
Shoulder Dystocia. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015/098, 10/2024)Peter Jakubowski, Harald Abele, Christian Bamberg, et al.
Journal of Cancer Research and Clinical Oncology|June 19, 2025
The efficacy and therapy management of nab-paclitaxel in the real-world setting for patients with advanced breast cancer - the SERAPHINA studyAndreas Schneeweiss, Peter A Fasching, Marc Thill, et al.
ESMO Open|November 28, 2021
Prognostic relevance of the HER2 status of circulating tumor cells in metastatic breast cancer patients screened for participation in the DETECT study programV Müller, M Banys-Paluchowski, T W P Friedl, et al.
Geburtshilfe Und Frauenheilkunde|February 10, 2025
Shoulder Dystocia. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015/098, 10/2024)Peter Jakubowski, Harald Abele, Christian Bamberg, et al.
Geburtshilfe Und Frauenheilkunde|December 27, 2019
Translational Highlights in Breast and Ovarian Cancer 2019 - Immunotherapy, DNA Repair, PI3K Inhibition and CDK4/6 TherapyAndreas D Hartkopf, Volkmar Müller, Achim Wöckel, et al.
Pageof 79